Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Physiomics (PYC) Share News

IN BRIEF: Physiomics wins "significant" GBP160,000 contract

7th Jun 2024 12:01

Physiomics PLC - Abingdon, Oxfordshire-based mathematical modelling and data science for new medicines - Says it has been awarded a significant contract by a new UK-based biotech client, which it left unnamed. "This client sits at the forefront of AI-driven design and development of novel therapies across various therapeutic areas," the company says. The project involves the use of Physiomics' Virtual Tumour technology to help guide the phase 1b/2 dosing regimens for one of their oncology assets and benchmark it against the competition. The project is valued at GBP161,580 and is anticipated to be completed over the next five months. Read More

EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech

1st Jun 2024 13:01

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday this week and not separately reported by Alliance News: Read More

IN BRIEF: Physiomics warns large contracts taken longer than expected

3rd May 2024 14:34

Physiomics PLC - Milton Park, England-based data science company, focused on new therapeutics and personalised medicine solutions - Warns several large contracts have taken longer than expected to be signed. It predicts total income for the year to June 30 will decline to a range of GBP600,000-GBP650,000 as a result. It adds: "The company is in the final stages of negotiation for two projects (one with an existing client and one with a potential new client), the total value of which is expected to be, in aggregate, approximately GBP350,000. Whilst the board anticipates that the contracts for these two projects will be signed in FY24, the majority of the revenue is now expected be recognised in the company's next financial year ending 30 June 2025, and accordingly the board's expectations for FY25 revenues have been correspondingly increased." Read More

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

3rd May 2024 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

IN BRIEF: Physiomics celebrates "substantial" contract with old client

18th Mar 2024 11:57

Physiomics PLC - mathematical modelling company that supports oncology drug development - Receives a "substantial" new contract by an existing "large pharma" client, though doesn't specify whom the client is. The project, which is valued at GBP178,000, involves involves pharmacokinetic-pharmacodynamic modelling in the field of DNA damage and repair fields. It is designed to help inform clinical dose and scheduling decisions. Physiomics expects this work to be completed over the course of the next six months. Read More

Physiomics reports higher interim revenue; loss narrows

7th Mar 2024 14:24

(Alliance News) - Physiomics PLC on Thursday reported higher interim revenue and a narrowed loss. Read More

UK earnings, trading statements calendar - next 7 days

4th Mar 2024 16:21

Read More

Physiomics celebrates contract award for cancer therapy insect model

19th Feb 2024 10:30

(Alliance News) - Physiomics PLC on Monday said that it has been awarded a contract by the University of Sheffield to support a grant-funded project focused on an insect model of cancer treatment. Read More

IN BRIEF: Physiomics wins deal to support client's oncology assets

5th Feb 2024 11:21

Physiomics PLC - mathematical modelling company that supports oncology drug development - Wins further contract from existing client Numab Therapeutics AG. Says the project involves pharmacokinetic-pharmacodynamic modelling in support of one of Numab's oncology assets entering the clinic and will help inform dose and scheduling decisions. Chief Executive Officer Peter Sargent comments: "We are thrilled to have this opportunity to continue working with and supporting Numab on this asset through its preclinical stages as it heads into the clinic. Along with the project we announced with them in August 2023, this new project is testament to the continued support we provide and the great relationships we've built." Read More

Physiomics appoints COO Sargent as new CEO; completes restructuring

22nd Jan 2024 12:35

(Alliance News) - Physiomics PLC shares fell on Monday, after it named Chief Operating Officer Peter Sargent as new chief executive, as Jim Millen becomes non-executive chair. Read More

UK shareholder meetings calendar - next 7 days

14th Nov 2023 15:49

Read More

Physiomics gets UK government grant for oncology dosing tool project

10th Nov 2023 10:26

(Alliance News) - Physiomics PLC on Friday said it has been awarded a grant by Innovate UK and the Office for Life Sciences as part of the UK government's 'advancing precision medicine' programme. Read More

Physiomics shares drop as annual loss widens; revenue falls

28th Sep 2023 12:12

(Alliance News) - Physiomics PLC on Thursday kept its outlook upbeat, despite reporting a drop in revenue in what it called a "difficult year." Read More

LONDON MARKET MIDDAY: Stocks stay downbeat; Digital 9 plunges 32%

28th Sep 2023 11:47

(Alliance News) - Stock prices in London were lower at midday on Thursday as elevated oil prices added fuel to inflationary fears and supported the higher for longer narrative around global interest rates. Read More

AIM WINNERS & LOSERS: Bradda shares surge on updated resource estimate

28th Sep 2023 10:44

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

Physiomics brings in chief operating officer; shares soar

4th Sep 2023 11:21

(Alliance News) - Physiomics PLC on Monday named Peter Sargent as its new chief operating officer. Read More

AIM WINNERS & LOSERS: Physiomics brings in COO; Ergomed receives bid

4th Sep 2023 10:27

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

LONDON MARKET CLOSE: FTSE 100 down amid stubborn US inflation

31st Aug 2023 16:50

(Alliance News) - Stock prices in London closed mixed on Thursday, after news that a key US inflation reading came in in line with market expectations. Read More

UPDATE: Physiomics wins new deal following Merck contract extension

31st Aug 2023 13:51

(Alliance News) - Physiomics PLC on Thursday said it won its first contract with an unnamed "UK-based biotech client". Read More

IN BRIEF: Physiomics to extend anti-cancer regimen work with Merck

31st Aug 2023 10:41

Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Has been awarded a further contract by existing client Merck KGaA involving pre-clinical and clinical modelling and simulation of anti-cancer regimens involving combinations of DNA damage and repair agents. Follows on previous Merck-commissioned projects. Expects the contract award to be completed over the next three months. Read More

FTSE 100 Latest
Value9,321.40
Change12.20